Cigna Group (NYSE:CI) Stock Price Expected to Rise, The Goldman Sachs Group Analyst Says

Key Points

• The Goldman Sachs Group raised its price target on Cigna to $340 (from $335) and kept a "buy" rating, implying roughly a 20% upside from the prior close.
• Analyst consensus is a Moderate Buy—including one Strong Buy, sixteen Buys and four Holds—with an average price target of $337.70, signaling broad analyst optimism.
• Cigna recently beat quarterly estimates (EPS $7.79 vs. $7.60; revenue $68.52B vs. $66.29B) and set FY2026 guidance at about 30.35 EPS, roughly in line with analyst forecasts of ~30.41.

Cigna Group (NYSE:CI - Get Free Report) had its price target raised by stock analysts at The Goldman Sachs Group from $335.00 to $340.00 in a research note issued to investors on Monday,MarketScreener reports. The brokerage currently has a "buy" rating on the health services provider's stock. The Goldman Sachs Group's price objective points to a potential upside of 20.06% from the stock's previous close.

A number of other research analysts also recently weighed in on the company. Barclays increased their target price on Cigna Group from $303.00 to $310.00 and gave the company an "overweight" rating in a report on Friday. Cantor Fitzgerald upped their price target on shares of Cigna Group from $325.00 to $340.00 and gave the company an "overweight" rating in a research report on Friday. Wells Fargo & Company increased their price objective on shares of Cigna Group from $300.00 to $305.00 and gave the stock an "equal weight" rating in a research note on Friday. Leerink Partners raised their price objective on shares of Cigna Group from $270.00 to $297.00 and gave the stock a "market perform" rating in a report on Friday, February 6th. Finally, Zacks Research upgraded shares of Cigna Group from a "strong sell" rating to a "hold" rating in a research report on Monday, January 5th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $337.70.

Cigna Group Trading Up 0.1%

NYSE:CI opened at $283.20 on Monday. The company has a market cap of $74.63 billion, a PE ratio of 11.96, a price-to-earnings-growth ratio of 0.98 and a beta of 0.30. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69. The company has a 50 day simple moving average of $274.34 and a two-hundred day simple moving average of $276.63. Cigna Group has a 12 month low of $239.51 and a 12 month high of $338.89.

Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, beating the consensus estimate of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The firm had revenue of $68.52 billion for the quarter, compared to analysts' expectations of $66.29 billion. During the same period in the prior year, the firm earned $6.74 EPS. The company's revenue was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Research analysts forecast that Cigna Group will post 30.41 earnings per share for the current year.

Insider Transactions at Cigna Group

In other news, insider Everett Neville sold 1,719 shares of the business's stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the transaction, the insider directly owned 5,670 shares in the company, valued at $1,638,119.70. The trade was a 23.26% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Nicole S. Jones sold 2,307 shares of the company's stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the transaction, the insider directly owned 32,647 shares of the company's stock, valued at approximately $9,432,044.77. This trade represents a 6.60% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.60% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Global Assets Advisory LLC bought a new stake in shares of Cigna Group in the 1st quarter valued at approximately $115,000. Diversify Wealth Management LLC lifted its position in Cigna Group by 88.1% in the first quarter. Diversify Wealth Management LLC now owns 3,961 shares of the health services provider's stock worth $1,158,000 after buying an additional 1,855 shares during the last quarter. Carnegie Investment Counsel boosted its stake in Cigna Group by 6.3% during the first quarter. Carnegie Investment Counsel now owns 3,752 shares of the health services provider's stock worth $1,001,000 after buying an additional 223 shares during the period. Citizens Financial Group Inc. RI increased its position in Cigna Group by 9.2% during the first quarter. Citizens Financial Group Inc. RI now owns 10,025 shares of the health services provider's stock valued at $2,674,000 after acquiring an additional 845 shares during the last quarter. Finally, Fifth Third Bancorp raised its stake in shares of Cigna Group by 211.9% in the first quarter. Fifth Third Bancorp now owns 76,660 shares of the health services provider's stock valued at $20,449,000 after acquiring an additional 52,078 shares during the period. 86.99% of the stock is currently owned by institutional investors.

Cigna Group Company Profile

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.